Biotechnology in the United Kingdom
MarketLine, August 2012, Pages: 33
Introduction
Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
- AstraZeneca PLC
- The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
- The UK biotechnology market had total revenues of $7.5 billion in 2011, representing a compound annual growth rate (CAGR) of 2.6% between 2007 and 2011.
- The medical/healthcare segment was the market's most lucrative in 2011, with total revenue of $5.2 billion, equivalent to 69.1% of the market's overall value.
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in the United Kingdom
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the United Kingdom economy
Key Questions Answered
What was the size of the United Kingdom biotechnology market by value in 2011?
What will be the size of the United Kingdom biotechnology market in 2016?
What factors are affecting the strength of competition in the United Kingdom biotechnology market?
How has the market performed over the last five years?
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 16
Degree of rivalry 17
Leading Companies 18
AstraZeneca PLC 18
GE Healthcare 22
Novartis AG 23
Sanofi SA 26
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related MarketLine research 32
LIST OF TABLES
Table 1: United Kingdom biotechnology market value: $ billion, 2007–11 8
Table 2: United Kingdom biotechnology market category segmentation: $ billion, 2011 9
Table 3: United Kingdom biotechnology market geography segmentation: $ billion, 2011 10
Table 4: United Kingdom biotechnology market value forecast: $ billion, 2011–16 11
Table 5: AstraZeneca PLC: key facts 18
Table 6: AstraZeneca PLC: key financials ($) 19
Table 7: AstraZeneca PLC: key financial ratios 20
Table 8: GE Healthcare: key facts 22
Table 9: Novartis AG: key facts 23
Table 10: Novartis AG: key financials ($) 24
Table 11: Novartis AG: key financial ratios 24
Table 12: Sanofi SA: key facts 26
Table 13: Sanofi SA: key financials ($) 27
Table 14: Sanofi SA: key financials (€) 27
Table 15: Sanofi SA: key financial ratios 27
Table 16: United Kingdom size of population (million), 2007–11 29
Table 17: United Kingdom gdp (constant 2000 prices, $ billion), 2007–11 29
Table 18: United Kingdom gdp (current prices, $ billion), 2007–11 29
Table 19: United Kingdom inflation, 2007–11 30
Table 20: United Kingdom consumer price index (absolute), 2007–11 30
Table 21: United Kingdom exchange rate, 2007–11 30
LIST OF FIGURES
Figure 1: United Kingdom biotechnology market value: $ billion, 2007–11 8
Figure 2: United Kingdom biotechnology market category segmentation: % share, by value, 2011 9
Figure 3: United Kingdom biotechnology market geography segmentation: % share, by value, 2011 10
Figure 4: United Kingdom biotechnology market value forecast: $ billion, 2011–16 11
Figure 5: Forces driving competition in the biotechnology market in the United Kingdom, 2011 12
Figure 6: Drivers of buyer power in the biotechnology market in the United Kingdom, 2011 13
Figure 7: Drivers of supplier power in the biotechnology market in the United Kingdom, 2011 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2011 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2011 16
Figure 10: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2011 17
Figure 11: AstraZeneca PLC: revenues & profitability 20
Figure 12: AstraZeneca PLC: assets & liabilities 21
Figure 13: Novartis AG: revenues & profitability 24
Figure 14: Novartis AG: assets & liabilities 25
Figure 15: Sanofi SA: revenues & profitability 28
Figure 16: Sanofi SA: assets & liabilities 28
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
